Familial Nasopharyngeal Carcinoma 6

146 R. Ove, R. R. Allison, and J. J. Luprogression-free survival analysis of a phase III randomizedtrial. J Clin Oncol 20(8):2038–2044Chang JT, See LC, et al (1996) The role of brachytherapy inearly-stage nasopharyngeal carcinoma. Int J Radiat OncolBiol Phys 36(5):1019–1024Chao KS, Ozyigit G, et al (2003) Patterns of failure in patients receivingdefinitive and postoperative IMRT for head-and-neckcancer. Int J Radiat Oncol Biol Phys 55(2):312–321Cheng SH, Tsai SY, et al (2000) Concomitant radiotherapy andchemotherapy for early-stage nasopharyngeal carcinoma.J Clin Oncol 18(10):2040–2045Chua DT, Ma J, et al (2006) Improvement of survival after additionof induction chemotherapy to radiotherapy in patientswith early-stage nasopharyngeal carcinoma: Subgroupanalysis of two Phase III trials. Int J Radiat Oncol Biol Phys65(5):1300–1306Chua DT, Sham JS, et al (1996) Prognostic value of paranasopharyngealextension of nasopharyngeal carcinoma. Asignificant factor in local control and distant metastasis.Cancer 78(2):202–210Chua DT, Sham JS, et al (1997) Retropharyngeal lymphadenopathyin patients with nasopharyngeal carcinoma: acomputed tomography-based study. Cancer 79(5):869–877Chua DT, Sham JS, et al (1998) Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trialcomparing cisplatin and epirubicin followed by radiotherapyversus radiotherapy alone in the treatment of patientswith locoregionally advanced nasopharyngeal carcinoma.Asian-Oceanian Clinical Oncology Association NasopharynxCancer Study Group. Cancer 83(11):2270–2283Chua DT, Sham JS, et al (2003a) Treatment outcome afterradiotherapy alone for patients with Stage I-II nasopharyngealcarcinoma. Cancer 98(1):74–80Chua DT, Sham JS, et al (2003b) Linear accelerator-based stereotacticradiosurgery for limited, locally persistent, andrecurrent nasopharyngeal carcinoma: efficacy and complications.Int J Radiat Oncol Biol Phys 56(1):177–183Cmelak AJ, Cox RS, et al (1997) Radiosurgery for skull basemalignancies and nasopharyngeal carcinoma. Int J RadiatOncol Biol Phys 37(5):997–1003Cooper JS, Cohen R, et al (1998) A comparison of staging systemsfor nasopharyngeal carcinoma. Cancer 83(2):213–219El-Weshi A, Khafaga Y, et al (2001) Neoadjuvant chemotherapyplus conventional radiotherapy or accelerated hyperfractionationin stage III and IV nasopharyngeal carcinoma—a phase II study. Acta Oncol 40(5):574–581Fang FM, Chien CY, et al (2008) Quality of life and survivaloutcome for patients with nasopharyngeal carcinomareceiving three-dimensional conformal radiotherapy vs.intensity-modulated radiotherapy-a longitudinal study. IntJ Radiat Oncol Biol Phys 72(2):356–364Fu KK, Pajak TF, et al (2000) A radiation therapy oncologygroup (RTOG) phase III randomized study to comparehyperfractionation and two variants of accelerated fractionationto standard fractionation radiotherapy for headand neck squamous cell carcinomas: first report of RTOG9003. Int J Radiat Oncol Biol Phys 48(1):7–16Hara W, Loo BW Jr, et al (2008) Excellent local control withstereotactic radiotherapy boost after external beam radiotherapyin patients with nasopharyngeal carcinoma. IntJ Radiat Oncol Biol Phys 71(2):393–400Ho JH (1972) Nasopharyngeal carcinoma (NPC). Adv CancerRes 15:57–92Ho JH (1978) Stage classification of nasopharyngeal carcinoma:a review. IARC Sci Publ (20):99–113Hong MH, Mai HQ, et al (2000) A comparison of the Chinese1992 and fifth-edition International Union Against Cancerstaging systems for staging nasopharyngeal carcinoma.Cancer 89(2):242–247Horiot JC, Lefur R, et al (1992) Status of the experience of theEORTC cooperative group of radiotherapy with hyperfractionatedand accelerated radiotherapy regimen. SeminRadiat Oncol 2:34–37Hsiung CY, Ting HM, et al (2006) Parotid-sparing intensitymodulatedradiotherapy (IMRT) for nasopharyngeal carcinoma:preserved parotid function after IMRT on quantitativesalivary scintigraphy, and comparison with historical dataafter conventional radiotherapy. Int J Radiat Oncol BiolPhys 66(2):454–461Hunt MA, Zelefsky MJ, et al (2001) Treatment planning anddelivery of intensity-modulated radiation therapy for primarynasopharynx cancer. Int J Radiat Oncol Biol Phys49(3):623–632Kwong DL, Pow EH, et al (2004) Intensity-modulated radiotherapyfor early-stage nasopharyngeal carcinoma: a prospectivestudy on disease control and preservation ofsalivary function. Cancer 101(7):1584–1593Lee AW, Lau WH, et al (2004) Prospective randomized study ontherapeutic gain achieved by addition of chemotherapy forT1–4N2–3M0 nasopharyngeal carcinoma (NPC).Proceedings of the American Society of Clinical Oncology.J Clin Oncol 22:5506Lee AW, Poon YF, et al (1992) Retrospective analysis of 5037patients with nasopharyngeal carcinoma treated during1976–1985: overall survival and patterns of failure. IntJ Radiat Oncol Biol Phys 23(2):261–270Lee N, Xia P, et al (2002) Intensity-modulated radiotherapy inthe treatment of nasopharyngeal carcinoma: an update ofthe UCSF experience. Int J Radiat Oncol Biol Phys53(1):12–22Lee N, Xia P, et al (2003) Intensity-modulated radiation therapyfor head-and-neck cancer: the UCSF experience focusingon target volume delineation. Int J Radiat Oncol BiolPhys 57(1):49–60Le QT, Tate D, et al (2003) Improved local control with stereotacticradiosurgical boost in patients with nasopharyngealcarcinoma. Int J Radiat Oncol Biol Phys 56(4):1046–1054Leung TW, Tung SY, et al (2005) Treatment results of 1070patients with nasopharyngeal carcinoma: an analysis ofsurvival and failure patterns. Head Neck 27(7):555–565Lu JJ, Shakespeare TP, et al (2004) Adjuvant fractionated highdose-rateintracavitary brachytherapy after external beamradiotherapy in Tl and T2 nasopharyngeal carcinoma.Head Neck 26(5):389–395Lu TX, Zhao C, et al (2005) Retrospective analysis of 934nasopharyngeal carcinoma patients treated with conventionalexternal beam radiotherapy alone]. ZhonghuaZhong Liu Za Zhi 27(10):620–622Ma J, Mai HQ, et al (2001) Results of a prospective randomizedtrial comparing neoadjuvant chemotherapy plus radiotherapywith radiotherapy alone in patients with locoregionallyadvanced nasopharyngeal carcinoma. J Clin Oncol19(5):1350–1357